Wednesday, February 14, 2007


MRI May Predict Multiple Sclerosis' Effect on Brain
HealthDay via Yahoo! News Wed, 14 Feb 2007 9:01 AM PST
WEDNESDAY, Feb. 14 (HealthDay News) -- MRI scans may be able to predict the rate of brain atrophy over the next two years in patients newly diagnosed with multiple sclerosis (MS), Dutch researchers say.

Patient Advocates With Multiple Sclerosis Fund Clinical Trial Of Promising Drug That Has Already Helped Thousands
Medical News Today Tue, 13 Feb 2007 3:12 PM PST
Over the last decade, anecdotal reports suggested that a very low dose of an FDA-approved drug called naltrexone provides effective symptom relief for many patients who suffer from Multiple Sclerosis. Frustrated by the lack of scientific research, volunteers began raising money to fund a human clinical trial of Low Dose Naltrexone (LDN) for MS. [click link for full article]

MS Brain Scan Might Predict Atrophy Rate
RedNova Tue, 13 Feb 2007 12:19 PM PST
Netherlands scientists say a brain scan of some multiple sclerosis patients might predict the rate of cerebral atrophy for the following two years. Dr.

Health Tip: Understanding Autoimmune Disorders
HealthDay via Yahoo! News Wed, 14 Feb 2007 6:01 AM PST
(HealthDay News) -- Autoimmune diseases occur when the body's immune system destroys its own healthy tissues instead of the foreign, harmful substances it was designed to fend off. The immune system typically defends the body from germs and toxins.

Gene Discovery Boosts Brain Cancer Research
HealthDay via Yahoo! News Wed, 14 Feb 2007 9:01 AM PST
WEDNESDAY, Feb. 14 (HealthDay News) -- Researchers have discovered that a gene that triggers the growth of stem cells during early brain development is also key to the growth of deadly adult brain tumors called gliomas.

BrainStorm Cell Therapeutics Initiates Stem Cell Safety Study in Primates for Parkinson's Disease
RedNova Wed, 14 Feb 2007 9:19 AM PST
BrainStorm Cell Therapeutics (OTCBB:BCLI), a leader in Adult Stem Cell Research, announced today that it has initiated a safety trial using an animal model of Parkinson's disease in primates.

0 Comments:

Post a Comment

<< Home